SB 400 New Hampshire Senate · 2026 Regular Session

relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

SB 400 requires New Hampshire's Therapeutic Cannabis Medical Oversight Board to review medical and scientific evidence about qualifying conditions for medical cannabis every two years. The board must also submit an annual report by January 1st, including specific citations to the evidence reviewed. This directly affects the oversight board, mandating structured updates to their review process and reporting transparency. The bill focuses on ensuring the board's decisions are consistently supported by current medical research.

Bill status passed both 4 of 5 stages cleared

Introduction

Nov 2025

Committee Review

Apr 2026

Senate Passage

Jan 2026

House Passage

Apr 2026

Governor

Introduced Nov 18, 2025 Last action May 21, 2026

Maddy AI version diff · 2 comparisons

What changed between versions

As Amended by the Senate → As Amended by the House · 2 edits

MINOR

The House removed the Senate's explicit requirement for the therapeutic cannabis medical oversight board to conduct biennial reviews of medical and scientific evidence. In exchange, the House expanded the annual reporting requirement to include documentation of the board's reviews, its findings and recommendations, and citations to evidence - rather than just citations alone. The net effect shifts from mandating a specific review schedule to requiring more detailed transparency about whatever reviews the board does conduct.

REQUIREMENT

The Senate version required the board to biennially (every two years) review medical and scientific evidence on currently approved and additional qualifying conditions. The House deleted this explicit biennial review mandate entirely.

The annual report requirement was expanded. The Senate version only required the report to include citations to medical and scientific evidence reviewed by the board. The House version requires the report to include documentation of the board's reviews, the board's findings and recommendations, AND citations to the evidence - making the reporting obligation substantially more detailed.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

May 6, 2026

Introduced

Sen. Pearl Moved Nonconcur with the House Amendment; Requests C of C, MA, VV; (In Recess 04/23/2026); SJ 11

upper

Apr 23, 2026

Lower · Passed

Ought to Pass with Amendment 2026-1309h: MA VV 04/23/2026 HJ 11 P. 8

lower

Apr 23, 2026

Introduced

Amendment # 2026-1309h: AA VV 04/23/2026 HJ 11 P. 8

lower

Apr 15, 2026

Lower · Passed

Committee Report: Ought to Pass with Amendment # 2026-1309h 04/08/2026 (Vote 13-1; CC)

lower

Feb 26, 2026

Introduced

Introduced (in recess of) 02/19/2026 and referred to Executive Departments and Administration HJ 5 P. 124

lower

Jan 29, 2026

Upper · Passed

Ought to Pass with Amendments #2026-0221s and #2026-0258s, MA, VV; OT3rdg; 01/29/2026; SJ 2

upper

Jan 29, 2026

Introduced

Sen. Gannon Floor Amendment # 2026-0258s, AA, VV; 01/29/2026; SJ 2

upper

Jan 29, 2026

Upper · Passed

Committee Amendment # 2026-0221s, AA, VV; 01/29/2026; SJ 2

upper

Jan 22, 2026

Upper · Passed

Committee Report: Ought to Pass with Amendment # 2026-0221s, 01/29/2026; Vote 4-0; CC; SC 3

upper

Nov 18, 2025

Introduced

Introduced 01/07/2026 and Referred to Executive Departments and Administration; SJ 1

upper

1 primary · 6 co-sponsors